Age at first birth and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers

Joanne Kotsopoulos, Jan Lubinski, Henry T. Lynch, Jan Klijn, Parviz Ghadirian, Susan L. Neuhausen, Charmaine Kim-Sing, William D. Foulkes, Pal Moller, Claudine Isaacs, Susan Domchek, Susan Randall, Kenneth Offit, Nadine Tung, Peter Ainsworth, Ruth Gershoni-Baruch, Andrea Eisen, Mary Daly, Beth Karlan, Howard M. SaalFergus Couch, Barbara Pasini, Teresa Wagner, Eitan Friedman, Gad Rennert, Charis Eng, Jeffrey Weitzel, Ping Sun, Steven A. Narod, J. Garber, D. Gilchrist, M. Osborne, D. Fishman, E. Warner, J. McLennan, W. McKinnon, S. Merajver, H. Olsson, D. Provencher, B. Pasche, G. Evans, W. S. Meschino, E. Lemire, A. Chudley, D. Rayson, C. Bellati

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

An early age at first full-term birth is associated with a reduction in the subsequent development of breast cancer among women in the general population. A similar effect has not yet been reported among women who carry an inherited BRCA1 or BRCA2 mutation. We conducted a matched case-control study on 1816 pairs of women with a BRCA1 (n = 1405) or BRCA2 (n = 411) mutation in an attempt to elucidate the relationship between age at first full-term pregnancy and the risk of developing breast cancer. Information about the age at first childbirth and other pregnancy-related variables was derived from a questionnaire administered to women during the course of genetic counselling. There was no difference in the mean age at first full-term birth in the cases and controls (24.9 years vs. 24.8 years; P = 0.81, respectively). Compared to women whose first child was born at or before 18 years of age, a later age at first full-term birth did not influence the risk of developing breast cancer (OR = 1.00 per year; 95% CI 0.98-1.03; P-trend = 0.67). Stratification by mutation status did not affect the results. These findings suggest that an early first full-term birth does not confer protection against breast cancer in BRCA mutation carriers. Nonetheless, BRCA mutation carriers opting for a prophylactic oophorectomy as a breast and/or ovarian cancer risk-reducing strategy should complete childbearing prior to age 40 when this prevention modality is most effective.

Original languageEnglish
Pages (from-to)221-228
Number of pages8
JournalBreast Cancer Research and Treatment
Volume105
Issue number2
DOIs
StatePublished - Oct 2007

Fingerprint

Birth Order
Term Birth
Breast Neoplasms
Mutation
Pregnancy
Genetic Counseling
Ovariectomy
Ovarian Neoplasms
Case-Control Studies
Parturition
Population

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Kotsopoulos, J., Lubinski, J., Lynch, H. T., Klijn, J., Ghadirian, P., Neuhausen, S. L., ... Bellati, C. (2007). Age at first birth and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. Breast Cancer Research and Treatment, 105(2), 221-228. https://doi.org/10.1007/s10549-006-9441-3

Age at first birth and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. / Kotsopoulos, Joanne; Lubinski, Jan; Lynch, Henry T.; Klijn, Jan; Ghadirian, Parviz; Neuhausen, Susan L.; Kim-Sing, Charmaine; Foulkes, William D.; Moller, Pal; Isaacs, Claudine; Domchek, Susan; Randall, Susan; Offit, Kenneth; Tung, Nadine; Ainsworth, Peter; Gershoni-Baruch, Ruth; Eisen, Andrea; Daly, Mary; Karlan, Beth; Saal, Howard M.; Couch, Fergus; Pasini, Barbara; Wagner, Teresa; Friedman, Eitan; Rennert, Gad; Eng, Charis; Weitzel, Jeffrey; Sun, Ping; Narod, Steven A.; Garber, J.; Gilchrist, D.; Osborne, M.; Fishman, D.; Warner, E.; McLennan, J.; McKinnon, W.; Merajver, S.; Olsson, H.; Provencher, D.; Pasche, B.; Evans, G.; Meschino, W. S.; Lemire, E.; Chudley, A.; Rayson, D.; Bellati, C.

In: Breast Cancer Research and Treatment, Vol. 105, No. 2, 10.2007, p. 221-228.

Research output: Contribution to journalArticle

Kotsopoulos, J, Lubinski, J, Lynch, HT, Klijn, J, Ghadirian, P, Neuhausen, SL, Kim-Sing, C, Foulkes, WD, Moller, P, Isaacs, C, Domchek, S, Randall, S, Offit, K, Tung, N, Ainsworth, P, Gershoni-Baruch, R, Eisen, A, Daly, M, Karlan, B, Saal, HM, Couch, F, Pasini, B, Wagner, T, Friedman, E, Rennert, G, Eng, C, Weitzel, J, Sun, P, Narod, SA, Garber, J, Gilchrist, D, Osborne, M, Fishman, D, Warner, E, McLennan, J, McKinnon, W, Merajver, S, Olsson, H, Provencher, D, Pasche, B, Evans, G, Meschino, WS, Lemire, E, Chudley, A, Rayson, D & Bellati, C 2007, 'Age at first birth and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers', Breast Cancer Research and Treatment, vol. 105, no. 2, pp. 221-228. https://doi.org/10.1007/s10549-006-9441-3
Kotsopoulos, Joanne ; Lubinski, Jan ; Lynch, Henry T. ; Klijn, Jan ; Ghadirian, Parviz ; Neuhausen, Susan L. ; Kim-Sing, Charmaine ; Foulkes, William D. ; Moller, Pal ; Isaacs, Claudine ; Domchek, Susan ; Randall, Susan ; Offit, Kenneth ; Tung, Nadine ; Ainsworth, Peter ; Gershoni-Baruch, Ruth ; Eisen, Andrea ; Daly, Mary ; Karlan, Beth ; Saal, Howard M. ; Couch, Fergus ; Pasini, Barbara ; Wagner, Teresa ; Friedman, Eitan ; Rennert, Gad ; Eng, Charis ; Weitzel, Jeffrey ; Sun, Ping ; Narod, Steven A. ; Garber, J. ; Gilchrist, D. ; Osborne, M. ; Fishman, D. ; Warner, E. ; McLennan, J. ; McKinnon, W. ; Merajver, S. ; Olsson, H. ; Provencher, D. ; Pasche, B. ; Evans, G. ; Meschino, W. S. ; Lemire, E. ; Chudley, A. ; Rayson, D. ; Bellati, C. / Age at first birth and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. In: Breast Cancer Research and Treatment. 2007 ; Vol. 105, No. 2. pp. 221-228.
@article{769b170a6a3d4ea880e237e1bd2f5c0c,
title = "Age at first birth and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers",
abstract = "An early age at first full-term birth is associated with a reduction in the subsequent development of breast cancer among women in the general population. A similar effect has not yet been reported among women who carry an inherited BRCA1 or BRCA2 mutation. We conducted a matched case-control study on 1816 pairs of women with a BRCA1 (n = 1405) or BRCA2 (n = 411) mutation in an attempt to elucidate the relationship between age at first full-term pregnancy and the risk of developing breast cancer. Information about the age at first childbirth and other pregnancy-related variables was derived from a questionnaire administered to women during the course of genetic counselling. There was no difference in the mean age at first full-term birth in the cases and controls (24.9 years vs. 24.8 years; P = 0.81, respectively). Compared to women whose first child was born at or before 18 years of age, a later age at first full-term birth did not influence the risk of developing breast cancer (OR = 1.00 per year; 95{\%} CI 0.98-1.03; P-trend = 0.67). Stratification by mutation status did not affect the results. These findings suggest that an early first full-term birth does not confer protection against breast cancer in BRCA mutation carriers. Nonetheless, BRCA mutation carriers opting for a prophylactic oophorectomy as a breast and/or ovarian cancer risk-reducing strategy should complete childbearing prior to age 40 when this prevention modality is most effective.",
author = "Joanne Kotsopoulos and Jan Lubinski and Lynch, {Henry T.} and Jan Klijn and Parviz Ghadirian and Neuhausen, {Susan L.} and Charmaine Kim-Sing and Foulkes, {William D.} and Pal Moller and Claudine Isaacs and Susan Domchek and Susan Randall and Kenneth Offit and Nadine Tung and Peter Ainsworth and Ruth Gershoni-Baruch and Andrea Eisen and Mary Daly and Beth Karlan and Saal, {Howard M.} and Fergus Couch and Barbara Pasini and Teresa Wagner and Eitan Friedman and Gad Rennert and Charis Eng and Jeffrey Weitzel and Ping Sun and Narod, {Steven A.} and J. Garber and D. Gilchrist and M. Osborne and D. Fishman and E. Warner and J. McLennan and W. McKinnon and S. Merajver and H. Olsson and D. Provencher and B. Pasche and G. Evans and Meschino, {W. S.} and E. Lemire and A. Chudley and D. Rayson and C. Bellati",
year = "2007",
month = "10",
doi = "10.1007/s10549-006-9441-3",
language = "English",
volume = "105",
pages = "221--228",
journal = "Breast Cancer Research and Treatment",
issn = "0167-6806",
publisher = "Springer New York",
number = "2",

}

TY - JOUR

T1 - Age at first birth and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers

AU - Kotsopoulos, Joanne

AU - Lubinski, Jan

AU - Lynch, Henry T.

AU - Klijn, Jan

AU - Ghadirian, Parviz

AU - Neuhausen, Susan L.

AU - Kim-Sing, Charmaine

AU - Foulkes, William D.

AU - Moller, Pal

AU - Isaacs, Claudine

AU - Domchek, Susan

AU - Randall, Susan

AU - Offit, Kenneth

AU - Tung, Nadine

AU - Ainsworth, Peter

AU - Gershoni-Baruch, Ruth

AU - Eisen, Andrea

AU - Daly, Mary

AU - Karlan, Beth

AU - Saal, Howard M.

AU - Couch, Fergus

AU - Pasini, Barbara

AU - Wagner, Teresa

AU - Friedman, Eitan

AU - Rennert, Gad

AU - Eng, Charis

AU - Weitzel, Jeffrey

AU - Sun, Ping

AU - Narod, Steven A.

AU - Garber, J.

AU - Gilchrist, D.

AU - Osborne, M.

AU - Fishman, D.

AU - Warner, E.

AU - McLennan, J.

AU - McKinnon, W.

AU - Merajver, S.

AU - Olsson, H.

AU - Provencher, D.

AU - Pasche, B.

AU - Evans, G.

AU - Meschino, W. S.

AU - Lemire, E.

AU - Chudley, A.

AU - Rayson, D.

AU - Bellati, C.

PY - 2007/10

Y1 - 2007/10

N2 - An early age at first full-term birth is associated with a reduction in the subsequent development of breast cancer among women in the general population. A similar effect has not yet been reported among women who carry an inherited BRCA1 or BRCA2 mutation. We conducted a matched case-control study on 1816 pairs of women with a BRCA1 (n = 1405) or BRCA2 (n = 411) mutation in an attempt to elucidate the relationship between age at first full-term pregnancy and the risk of developing breast cancer. Information about the age at first childbirth and other pregnancy-related variables was derived from a questionnaire administered to women during the course of genetic counselling. There was no difference in the mean age at first full-term birth in the cases and controls (24.9 years vs. 24.8 years; P = 0.81, respectively). Compared to women whose first child was born at or before 18 years of age, a later age at first full-term birth did not influence the risk of developing breast cancer (OR = 1.00 per year; 95% CI 0.98-1.03; P-trend = 0.67). Stratification by mutation status did not affect the results. These findings suggest that an early first full-term birth does not confer protection against breast cancer in BRCA mutation carriers. Nonetheless, BRCA mutation carriers opting for a prophylactic oophorectomy as a breast and/or ovarian cancer risk-reducing strategy should complete childbearing prior to age 40 when this prevention modality is most effective.

AB - An early age at first full-term birth is associated with a reduction in the subsequent development of breast cancer among women in the general population. A similar effect has not yet been reported among women who carry an inherited BRCA1 or BRCA2 mutation. We conducted a matched case-control study on 1816 pairs of women with a BRCA1 (n = 1405) or BRCA2 (n = 411) mutation in an attempt to elucidate the relationship between age at first full-term pregnancy and the risk of developing breast cancer. Information about the age at first childbirth and other pregnancy-related variables was derived from a questionnaire administered to women during the course of genetic counselling. There was no difference in the mean age at first full-term birth in the cases and controls (24.9 years vs. 24.8 years; P = 0.81, respectively). Compared to women whose first child was born at or before 18 years of age, a later age at first full-term birth did not influence the risk of developing breast cancer (OR = 1.00 per year; 95% CI 0.98-1.03; P-trend = 0.67). Stratification by mutation status did not affect the results. These findings suggest that an early first full-term birth does not confer protection against breast cancer in BRCA mutation carriers. Nonetheless, BRCA mutation carriers opting for a prophylactic oophorectomy as a breast and/or ovarian cancer risk-reducing strategy should complete childbearing prior to age 40 when this prevention modality is most effective.

UR - http://www.scopus.com/inward/record.url?scp=34548436454&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548436454&partnerID=8YFLogxK

U2 - 10.1007/s10549-006-9441-3

DO - 10.1007/s10549-006-9441-3

M3 - Article

C2 - 17245541

AN - SCOPUS:34548436454

VL - 105

SP - 221

EP - 228

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

SN - 0167-6806

IS - 2

ER -